Statements (50)
Predicate | Object |
---|---|
gptkbp:instanceOf |
leukemia
hematologic cancer |
gptkbp:hasCommonDrug |
gptkb:cyclophosphamide
gptkb:rituximab gptkb:prednisone gptkb:doxorubicin gptkb:vincristine |
gptkbp:hasCommonTreatment |
radiation therapy
chemotherapy immunotherapy stem cell transplant |
gptkbp:hasDiagnosticMethod |
gptkb:CT_scan
PET scan immunophenotyping lymph node biopsy |
gptkbp:hasEpidemiology |
slightly more common in males
more common in adults incidence increases with age |
https://www.w3.org/2000/01/rdf-schema#label |
B-cell non-Hodgkin lymphoma
|
gptkbp:ICD-10_code |
C83
C85 |
gptkbp:originatedIn |
B lymphocyte
|
gptkbp:prevalence |
most common type of non-Hodgkin lymphoma
|
gptkbp:prognosis |
age
stage at diagnosis varies by subtype performance status can be indolent or aggressive lactate dehydrogenase level number of extranodal sites |
gptkbp:relatedTo |
Hodgkin lymphoma
chronic lymphocytic leukemia T-cell non-Hodgkin lymphoma |
gptkbp:riskFactor |
gptkb:Epstein-Barr_virus_infection
HIV infection immunosuppressive therapy immunodeficiency autoimmune disease |
gptkbp:subspecies |
gptkb:Burkitt_lymphoma
gptkb:mantle_cell_lymphoma gptkb:marginal_zone_lymphoma diffuse large B-cell lymphoma follicular lymphoma |
gptkbp:symptom |
fever
weight loss lymphadenopathy night sweats |
gptkbp:bfsParent |
gptkb:ATG-101
gptkb:UCART22 |
gptkbp:bfsLayer |
8
|